|
Real-time Estimate
Cboe BZX
13:56:44 2026-10-01 EDT
|
5-day change | 1st Jan Change | ||
| 2.965 USD | -11.49% |
|
-18.23% | -80.11% |
| 09-20 | Seres Therapeutics, Inc.(NasdaqGS:MCRB) dropped from S&P Global BMI Index | CI |
| 08-13 | Seres Therapeutics Files $300 Million Mixed Shelf | MT |
Company Valuation: Seres Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 765.1 | 697.7 | 181 | 141.9 | 134.6 | 33.3 | - | - |
| Change | - | -8.81% | -74.06% | -21.59% | -5.12% | -75.26% | - | - |
| Enterprise Value (EV) | 634.3 | 697.3 | 266.9 | 202.7 | 134.6 | 33.3 | 33.3 | 33.3 |
| Change | - | 9.93% | -61.72% | -24.05% | -33.6% | -75.26% | 0% | 0% |
| P/E | -11.6x | -2.42x | -1.57x | - | 23.3x | -0.95x | -0.68x | -0.67x |
| PBR | - | - | -4.21x | 10.4x | - | - | - | - |
| PEG | - | -0x | 0x | - | - | 0x | -0x | -1.1x |
| Capitalization / Revenue | 5.28x | 97.9x | 1.43x | - | 171x | 2.41x | 122x | 122x |
| EV / Revenue | 0x | 0x | 0x | - | 0x | 2.41x | 122x | 122x |
| EV / EBITDA | -0x | -0x | -0x | -0x | - | -0.45x | -0.43x | -0.39x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -0.5x | -0.42x | -0.38x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -14.4 | -46.2 | -17.8 | - | 0.64 | -3.515 | -4.945 | -4.975 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 144.9 | 7.128 | 126.3 | - | 0.789 | 13.8 | 0.2735 | 0.2735 |
| EBITDA 1 | -58.55 | -239.9 | -96.14 | -115.8 | - | -74.6 | -77.3 | -85 |
| EBIT 1 | -64.49 | -246.5 | -102.4 | -121.3 | -93.97 | -66.09 | -79.44 | -88.13 |
| Net income 1 | -65.58 | -250.2 | -113.7 | 0.136 | 5.696 | -37.49 | -78.95 | -87.69 |
| Net Debt | -130.8 | -0.44 | 85.97 | 60.85 | - | - | - | - |
| Reference price 2 | 166.600 | 112.000 | 28.000 | 16.620 | 14.880 | 3.350 | 3.350 | 3.350 |
| Nbr of stocks (in thousands) | 4,592 | 6,230 | 6,463 | 8,537 | 9,047 | 9,941 | - | - |
| Announcement Date | 3/1/22 | 3/7/23 | 3/5/24 | 3/13/25 | 3/12/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.95x | - | - | - | 33.3M | |
| 21.73x | 7.77x | 15.61x | 1.37% | 74.46B | |
| 31.25x | 9.01x | 28.06x | 0.04% | 60.14B | |
| 33.64x | 6.03x | 18.07x | 0.97% | 48.15B | |
| 34.63x | 3.34x | 14.4x | -.--% | 44.25B | |
| -21.16x | 229.18x | -22.81x | -.--% | 43.99B | |
| 47.94x | 5.54x | 30.43x | -.--% | 41.61B | |
| 26.89x | 7.76x | 19.96x | 0.42% | 29.97B | |
| 33.91x | 7.26x | 18.84x | -.--% | 29.31B | |
| -70.02x | 13.44x | -68.51x | -.--% | 24.93B | |
| Average | 13.79x | 32.15x | 6.01x | 0.31% | 39.68B | |
| Weighted average by Cap. | 19.57x | 31.88x | 10.24x | 0.41% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- MCRB Stock
- Valuation Seres Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
